Glenmede Trust’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $887K | Buy |
7,607
+2,141
| +39% | +$250K | ﹤0.01% | 736 |
|
|
2024
Q4 | $462K | Sell |
5,466
-2,007
| -27% | -$170K | ﹤0.01% | 960 |
|
|
2024
Q3 | $672K | Buy |
7,473
+70
| +0.9% | +$6.29K | ﹤0.01% | 839 |
|
|
2024
Q2 | $596K | Buy |
7,403
+101
| +1% | +$8.13K | ﹤0.01% | 842 |
|
|
2024
Q1 | $583K | Sell |
7,302
-63
| -0.9% | -$5.03K | ﹤0.01% | 873 |
|
|
2023
Q4 | $586K | Sell |
7,365
-838
| -10% | -$66.7K | ﹤0.01% | 846 |
|
|
2023
Q3 | $573K | Buy |
8,203
+4,031
| +97% | +$282K | ﹤0.01% | 802 |
|
|
2023
Q2 | $257K | Hold |
4,172
| – | – | ﹤0.01% | 1022 |
|
|
2023
Q1 | $257K | Sell |
4,172
-2,390
| -36% | -$147K | ﹤0.01% | 1027 |
|
|
2022
Q4 | $506K | Sell |
6,562
-8,999
| -58% | -$694K | ﹤0.01% | 833 |
|
|
2022
Q3 | $694K | Buy |
15,561
+9,876
| +174% | +$440K | ﹤0.01% | 738 |
|
|
2022
Q2 | $217K | Buy |
+5,685
| New | +$217K | ﹤0.01% | 1083 |
|
|
2022
Q1 | – | Sell |
-5,535
| Closed | -$209K | – | 1325 |
|
|
2021
Q4 | $209K | Buy |
+5,535
| New | +$209K | ﹤0.01% | 1143 |
|
|
2021
Q3 | – | Sell |
-5,500
| Closed | -$371K | – | 1294 |
|
|
2021
Q2 | $371K | Sell |
5,500
-235
| -4% | -$15.9K | ﹤0.01% | 973 |
|
|
2021
Q1 | $324K | Buy |
5,735
+60
| +1% | +$3.39K | ﹤0.01% | 962 |
|
|
2020
Q4 | $462K | Buy |
5,675
+562
| +11% | +$45.8K | ﹤0.01% | 858 |
|
|
2020
Q3 | $364K | Buy |
5,113
+2,480
| +94% | +$177K | ﹤0.01% | 874 |
|
|
2020
Q2 | $216K | Sell |
2,633
-2,473
| -48% | -$203K | ﹤0.01% | 985 |
|
|
2020
Q1 | $527K | Hold |
5,106
| – | – | ﹤0.01% | 889 |
|
|
2019
Q4 | $527K | Sell |
5,106
-899
| -15% | -$92.8K | ﹤0.01% | 889 |
|
|
2019
Q3 | $121 | Buy |
6,005
+2,545
| +74% | +$51 | ﹤0.01% | 1338 |
|
|
2019
Q2 | $89 | Buy |
+3,460
| New | +$89 | ﹤0.01% | 1440 |
|